Results 141 to 150 of about 17,554 (214)

Estimating risk of reported versus theoretical drug-drug interactions in headaches medicine: an exhaustive comparison between DrugBank and FAERS database for abortive and preventive combinations. [PDF]

J Oral Facial Pain Headache
Kaytser V, Hakkinen I, Dave J, Zhang P.
europepmc   +1 more source

Letter to the Editor: Fimasartan-Induced Liver Injury and Update on Hepatotoxicity Risks. [PDF]

J Korean Med Sci
Lee J, Chin S, Kim SG, Kim YS, Yoo JJ.
europepmc   +1 more source

How difficult is the diagnosis of heart failure with preserved ejection fraction. [PDF]

Eur Heart J Suppl
Cesari A, Sacco A, Oliva FG.
europepmc   +1 more source

Computational Engineering of siderocalin to modulate its binding affinity to the antihypertension drug candesartan. [PDF]

J Struct Biol
Vogel K, Moeller J, Bozhanova NG, Voehler M, Penk A, Meiler J, Schoeder CT.   +6 more
europepmc   +1 more source

Immunomodulatory Effects of RAAS Inhibitors: Beyond Hypertension and Heart Failure. [PDF]

Biomedicines
Haliga RE, Cojocaru E, Sîrbu O, Hrițcu I, Alexa RE, Haliga IB, Șorodoc V, Coman AE.   +7 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Candesartan

Cardiovascular Drug Reviews, 2004
ABSTRACTCandesartan cilexetil is the prodrug of candesartan, an angiotensin II receptor antagonist. Candesartan binds selectively and non‐competitively to the angiotensin II receptor type 1, thus preventing the actions of angiotensin II. Clinical trials have demonstrated its efficacy at a dose range of 2 to 32 mg once daily in hypertension of all ...
Christoph H Gleiter
exaly   +3 more sources

Candesartan in migraine prevention: results from a retrospective real-world study

Journal of Neurology, 2020
Randomized studies have reported a positive effect of candesartan, an angiotensin II receptor antagonist, in migraine prevention. The aim of our study was to explore patient subjective efficacy of candesartan in a real-world sample of migraine patients ...
Roberta Messina, Massimo Filippi
exaly   +3 more sources